Join Telegram
LIVE01 Oct 2026, 11:37 PM IST
Home / IPO / Chandra Bhagat Pharma
LISTEDSME

Chandra Bhagat Pharma IPO

Open 31st Jan 2020 · Close 6th Feb 2020 · Listing 14th Feb 2020

Verified 2026-09-0889% data coverage
Issue Price₹51.00
Listing Price₹51.70
Current Price—
Listing Gain1.37%
Current Return—

At a glance

Updated 2026-09-08

The shares listed at ₹51.70, a 1.37% move from the issue price. Chandra Bhagat Pharma is a SME IPO with an issue size of ₹10.20 crore, proposed for listing on BSE SME. The offer opens on 31st Jan 2020 and closes on 6th Feb 2020. The issue structure includes a fresh issue of ₹9.69 crore. The current listing schedule points to 14th Feb 2020.

Issue details

Listing atBSE SME
Issue typeFixed Price Issue
Issue size₹10.20 Cr
Fresh issue₹9.69 Cr
Face value₹10
Price band—–—
Allotment11th Feb 2020
Listing14th Feb 2020

Listing performance

Full performance ↗
Issue price₹51.00
Listing price₹51.70
Current price—
Listing gain1.37%
Current return—
Price progressionIssue → Listing → Current

Grey market

GMP page ↗
Latest GMP₹0.00
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.

Timeline

Opens31st Jan 2020
Closes6th Feb 2020
Allotment11th Feb 2020
Refund13th Feb 2020
Demat13th Feb 2020
Listing14th Feb 2020

Subscription demand

Full bidding ↗
Total1.65×

Lot size

InvestorLotsSharesAmount
Minimum Bid12000—

Company

Incorporated2003

Use of proceeds

ObjectAmount
To Meet Incremental Working Capital Requirements₹7.00 Cr
Setting up Distribution and Warehousing Centre’s₹1.50 Cr
General Corporate Purpose₹0.95 Cr
To meet Public Issue Expenses₹0.75 Cr

Financial performance

Year-wise operating scale, profitability and balance-sheet context.
Full financials ↗
Assets85.94₹ Cr · +53.7% vs prior year
Net Worth14.61₹ Cr · +97.2% vs prior year

FY19

Assets82.86
Net Worth14.37
Total Debt27.82
RevenueAnnualised basis106.28
EBITDAAnnualised basis4.67
PATAnnualised basis0.63
EBITDA Margin (%)4.39

FY18

Assets58.06
Net Worth8.45
Total Debt21.75
RevenueAnnualised basis97.06
EBITDAAnnualised basis4.75
PATAnnualised basis1.03
EBITDA Margin (%)4.89

FY17

Assets55.90
Net Worth7.41
Total Debt20.50
RevenueAnnualised basis89.79
EBITDAAnnualised basis4.39
PATAnnualised basis0.66
EBITDA Margin (%)4.89

31-Jul-19

Assets85.94
Net Worth14.61
Total Debt26.83
RevenueAnnualised basis33.35
EBITDAAnnualised basis1.47
PATAnnualised basis0.25

KPIs

KPIIssue ExpensesEst Amt (₹ Cr.)
1Lead Manger Fees including Underwriting Commission0.18
2Fees Payable to Registrar to the Issue0.01
3Fees Payable for Marketing and Advertisement Expenses0.38
4Fees Payable to Regulators including Stock Exchanges0.03
5Payment for Printing and Distribution of Issue Stationaries0.01
6Others (Fees Payable to Peer Review Auditor, Fees to Legal Advisors, Marketing Expenses, Custodians Fees, Market Making, Brokerage, Processing Fees for Application and Miscellaneous Expenses)0.14
7Processing Fees to SCSBs for ASBA Application Procured by the Members of the Syndicate or Registered Brokers and Submitted with SCSB’s0
8Processing Fees Issued to Issuer Bank for UPI Mechanism w.r.t. Application forms procured by the members of the Syndicate, Registered Brokers, RTAs or the CDP’s and submitted to them0

Valuation & shareholding

Pre-IPO P/E51
Promoter holding pre96.72%
Promoter holding post71.08%
Market cap₹38.48 Cr.

Peer comparison

CompanyEPSP/ERoNWNAV
Chandra Bhagat Pharma Ltd IPO—51.00 x——
Bio Medica IPO—13.45 x——
Goldline Pharmaceutical IPO—14.56 x——
Speciality Medicines IPO—10.49 x——

Issue expenses

ExpenseAmount
To Meet Incremental Working Capital Requirements₹7.00 Cr
Setting up Distribution and Warehousing Centre’s₹1.50 Cr
General Corporate Purpose₹0.95 Cr
To meet Public Issue Expenses₹0.75 Cr

Registrar & lead managers

Registrar

MUFG Intime India Pvt.Ltd.

Lead managers

  • JDA Capital Services Ltd.

Offer documents

Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-08.
IPO UPDATE ALERTS

Track Chandra Bhagat Pharma without missing an update

Register for subscription, GMP, allotment and listing notifications.

Register for IPO Updates →